therapeutic development

3 articles
GlobeNewswire Inc.GlobeNewswire Inc.··Delveinsight

Complement Inhibitors Market Set for Robust Growth Through 2036 as C5, C3 Therapies Expand

Complement inhibitors market projected for strong growth through 2036, driven by rising disease prevalence and C5/C3-targeted drug approvals across multiple indications.
NVSSNYRHHBYAZNREGN+3clinical trialsmarket growth
GlobeNewswire Inc.GlobeNewswire Inc.··Na

BullFrog AI Launches bfARENAS Decision Engine to Combat 90% Clinical Trial Failure Rate

BullFrog AI ($BFRG) launches bfARENAS, a scenario-based decision engine designed to optimize drug portfolio strategy and clinical trial design for biotech firms.
BFRGBFRGWbiotechclinical trials
BenzingaBenzinga··Vandana Singh

Merck Partners With Mayo Clinic on AI-Driven Drug Discovery Initiative

Merck partners with Mayo Clinic to use AI and advanced analytics for drug discovery, focusing on inflammatory bowel disease, atopic dermatitis, and multiple sclerosis treatment development.
MRKclinical datastrategic partnership